Food & Beverages
Global Glucoraphanin and Sulforaphane Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 569474
- Pages: 142
- Figures: 139
- Views: 8
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Glucoraphanin and Sulforaphane market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Brassica
CS Health
Ingood by Olga
ETChem
Pioneer Herb Industrial
Shanxi Yian
Anhui Bensentang Biotechnology
Segment by Type
Glucoraphanin
Sulforaphane
Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Glucoraphanin and Sulforaphane study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Glucoraphanin and Sulforaphane market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Brassica
CS Health
Ingood by Olga
ETChem
Pioneer Herb Industrial
Shanxi Yian
Anhui Bensentang Biotechnology
Segment by Type
Glucoraphanin
Sulforaphane
Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Glucoraphanin and Sulforaphane study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Glucoraphanin and Sulforaphane: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glucoraphanin and Sulforaphane Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Glucoraphanin
1.2.3 Sulforaphane
1.3 Market Segmentation by Application
1.3.1 Global Glucoraphanin and Sulforaphane Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Products
1.3.3 Functional Foods
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glucoraphanin and Sulforaphane Revenue Estimates and Forecasts 2020-2031
2.2 Global Glucoraphanin and Sulforaphane Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Glucoraphanin and Sulforaphane Sales Estimates and Forecasts 2020-2031
2.4 Global Glucoraphanin and Sulforaphane Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Glucoraphanin and Sulforaphane Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Glucoraphanin and Sulforaphane Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Glucoraphanin Market Size by Manufacturers
3.5.2 Sulforaphane Market Size by Manufacturers
3.6 Global Glucoraphanin and Sulforaphane Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Glucoraphanin and Sulforaphane Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Glucoraphanin and Sulforaphane Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Glucoraphanin and Sulforaphane Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glucoraphanin and Sulforaphane Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
6.4 North America Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Glucoraphanin and Sulforaphane Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
7.4 Europe Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Glucoraphanin and Sulforaphane Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Glucoraphanin and Sulforaphane Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
9.4 Central and South America Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Glucoraphanin and Sulforaphane Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Glucoraphanin and Sulforaphane Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Brassica
11.1.1 Brassica Corporation Information
11.1.2 Brassica Business Overview
11.1.3 Brassica Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.1.4 Brassica Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Brassica Glucoraphanin and Sulforaphane Sales by Product in 2024
11.1.6 Brassica Glucoraphanin and Sulforaphane Sales by Application in 2024
11.1.7 Brassica Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.1.8 Brassica Glucoraphanin and Sulforaphane SWOT Analysis
11.1.9 Brassica Recent Developments
11.2 CS Health
11.2.1 CS Health Corporation Information
11.2.2 CS Health Business Overview
11.2.3 CS Health Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.2.4 CS Health Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 CS Health Glucoraphanin and Sulforaphane Sales by Product in 2024
11.2.6 CS Health Glucoraphanin and Sulforaphane Sales by Application in 2024
11.2.7 CS Health Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.2.8 CS Health Glucoraphanin and Sulforaphane SWOT Analysis
11.2.9 CS Health Recent Developments
11.3 Ingood by Olga
11.3.1 Ingood by Olga Corporation Information
11.3.2 Ingood by Olga Business Overview
11.3.3 Ingood by Olga Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.3.4 Ingood by Olga Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Product in 2024
11.3.6 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Application in 2024
11.3.7 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.3.8 Ingood by Olga Glucoraphanin and Sulforaphane SWOT Analysis
11.3.9 Ingood by Olga Recent Developments
11.4 ETChem
11.4.1 ETChem Corporation Information
11.4.2 ETChem Business Overview
11.4.3 ETChem Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.4.4 ETChem Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ETChem Glucoraphanin and Sulforaphane Sales by Product in 2024
11.4.6 ETChem Glucoraphanin and Sulforaphane Sales by Application in 2024
11.4.7 ETChem Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.4.8 ETChem Glucoraphanin and Sulforaphane SWOT Analysis
11.4.9 ETChem Recent Developments
11.5 Pioneer Herb Industrial
11.5.1 Pioneer Herb Industrial Corporation Information
11.5.2 Pioneer Herb Industrial Business Overview
11.5.3 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.5.4 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Product in 2024
11.5.6 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Application in 2024
11.5.7 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.5.8 Pioneer Herb Industrial Glucoraphanin and Sulforaphane SWOT Analysis
11.5.9 Pioneer Herb Industrial Recent Developments
11.6 Shanxi Yian
11.6.1 Shanxi Yian Corporation Information
11.6.2 Shanxi Yian Business Overview
11.6.3 Shanxi Yian Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.6.4 Shanxi Yian Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shanxi Yian Recent Developments
11.7 Anhui Bensentang Biotechnology
11.7.1 Anhui Bensentang Biotechnology Corporation Information
11.7.2 Anhui Bensentang Biotechnology Business Overview
11.7.3 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.7.4 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Anhui Bensentang Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Glucoraphanin and Sulforaphane Industry Chain
12.2 Glucoraphanin and Sulforaphane Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Glucoraphanin and Sulforaphane Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Glucoraphanin and Sulforaphane Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Glucoraphanin and Sulforaphane Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Glucoraphanin and Sulforaphane Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Glucoraphanin and Sulforaphane: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glucoraphanin and Sulforaphane Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Glucoraphanin
1.2.3 Sulforaphane
1.3 Market Segmentation by Application
1.3.1 Global Glucoraphanin and Sulforaphane Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Products
1.3.3 Functional Foods
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glucoraphanin and Sulforaphane Revenue Estimates and Forecasts 2020-2031
2.2 Global Glucoraphanin and Sulforaphane Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Glucoraphanin and Sulforaphane Sales Estimates and Forecasts 2020-2031
2.4 Global Glucoraphanin and Sulforaphane Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Glucoraphanin and Sulforaphane Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Glucoraphanin and Sulforaphane Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Glucoraphanin Market Size by Manufacturers
3.5.2 Sulforaphane Market Size by Manufacturers
3.6 Global Glucoraphanin and Sulforaphane Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Glucoraphanin and Sulforaphane Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Glucoraphanin and Sulforaphane Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Glucoraphanin and Sulforaphane Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glucoraphanin and Sulforaphane Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
6.4 North America Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Glucoraphanin and Sulforaphane Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
7.4 Europe Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Glucoraphanin and Sulforaphane Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Glucoraphanin and Sulforaphane Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
9.4 Central and South America Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Glucoraphanin and Sulforaphane Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Glucoraphanin and Sulforaphane Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Glucoraphanin and Sulforaphane Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Glucoraphanin and Sulforaphane Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Brassica
11.1.1 Brassica Corporation Information
11.1.2 Brassica Business Overview
11.1.3 Brassica Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.1.4 Brassica Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Brassica Glucoraphanin and Sulforaphane Sales by Product in 2024
11.1.6 Brassica Glucoraphanin and Sulforaphane Sales by Application in 2024
11.1.7 Brassica Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.1.8 Brassica Glucoraphanin and Sulforaphane SWOT Analysis
11.1.9 Brassica Recent Developments
11.2 CS Health
11.2.1 CS Health Corporation Information
11.2.2 CS Health Business Overview
11.2.3 CS Health Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.2.4 CS Health Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 CS Health Glucoraphanin and Sulforaphane Sales by Product in 2024
11.2.6 CS Health Glucoraphanin and Sulforaphane Sales by Application in 2024
11.2.7 CS Health Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.2.8 CS Health Glucoraphanin and Sulforaphane SWOT Analysis
11.2.9 CS Health Recent Developments
11.3 Ingood by Olga
11.3.1 Ingood by Olga Corporation Information
11.3.2 Ingood by Olga Business Overview
11.3.3 Ingood by Olga Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.3.4 Ingood by Olga Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Product in 2024
11.3.6 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Application in 2024
11.3.7 Ingood by Olga Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.3.8 Ingood by Olga Glucoraphanin and Sulforaphane SWOT Analysis
11.3.9 Ingood by Olga Recent Developments
11.4 ETChem
11.4.1 ETChem Corporation Information
11.4.2 ETChem Business Overview
11.4.3 ETChem Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.4.4 ETChem Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ETChem Glucoraphanin and Sulforaphane Sales by Product in 2024
11.4.6 ETChem Glucoraphanin and Sulforaphane Sales by Application in 2024
11.4.7 ETChem Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.4.8 ETChem Glucoraphanin and Sulforaphane SWOT Analysis
11.4.9 ETChem Recent Developments
11.5 Pioneer Herb Industrial
11.5.1 Pioneer Herb Industrial Corporation Information
11.5.2 Pioneer Herb Industrial Business Overview
11.5.3 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.5.4 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Product in 2024
11.5.6 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Application in 2024
11.5.7 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales by Geographic Area in 2024
11.5.8 Pioneer Herb Industrial Glucoraphanin and Sulforaphane SWOT Analysis
11.5.9 Pioneer Herb Industrial Recent Developments
11.6 Shanxi Yian
11.6.1 Shanxi Yian Corporation Information
11.6.2 Shanxi Yian Business Overview
11.6.3 Shanxi Yian Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.6.4 Shanxi Yian Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shanxi Yian Recent Developments
11.7 Anhui Bensentang Biotechnology
11.7.1 Anhui Bensentang Biotechnology Corporation Information
11.7.2 Anhui Bensentang Biotechnology Business Overview
11.7.3 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Product Models, Descriptions and Specifications
11.7.4 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Anhui Bensentang Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Glucoraphanin and Sulforaphane Industry Chain
12.2 Glucoraphanin and Sulforaphane Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Glucoraphanin and Sulforaphane Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Glucoraphanin and Sulforaphane Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Glucoraphanin and Sulforaphane Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Glucoraphanin and Sulforaphane Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Glucoraphanin and Sulforaphane Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Glucoraphanin and Sulforaphane Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Glucoraphanin and Sulforaphane Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Glucoraphanin and Sulforaphane Sales by Region (2020-2025) & (Kg)
Table 8. Global Glucoraphanin and Sulforaphane Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Glucoraphanin and Sulforaphane Sales by Manufacturers (2020-2025) & (Kg)
Table 11. Global Glucoraphanin and Sulforaphane Sales Share by Manufacturers (2020-2025)
Table 12. Global Glucoraphanin and Sulforaphane Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Glucoraphanin and Sulforaphane Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Glucoraphanin and Sulforaphane by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucoraphanin and Sulforaphane as of 2024)
Table 16. Global Glucoraphanin and Sulforaphane Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Glucoraphanin and Sulforaphane Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
Table 18. Key Manufacturers Glucoraphanin and Sulforaphane Manufacturing Base and Headquarters
Table 19. Global Glucoraphanin and Sulforaphane Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Glucoraphanin and Sulforaphane Sales by Type (2020-2025) & (Kg)
Table 23. Global Glucoraphanin and Sulforaphane Sales by Type (2026-2031) & (Kg)
Table 24. Global Glucoraphanin and Sulforaphane Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Glucoraphanin and Sulforaphane Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Glucoraphanin and Sulforaphane ASP by Type (2020-2031) & (US$/Kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Glucoraphanin and Sulforaphane Sales by Application (2020-2025) & (Kg)
Table 29. Global Glucoraphanin and Sulforaphane Sales by Application (2026-2031) & (Kg)
Table 30. Glucoraphanin and Sulforaphane High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Glucoraphanin and Sulforaphane Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Glucoraphanin and Sulforaphane Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Glucoraphanin and Sulforaphane ASP by Application (2020-2031) & (US$/Kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 37. North America Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 40. Europe Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 45. Southeast Asia Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Glucoraphanin and Sulforaphane Investment Opportunities and Key Challenges
Table 47. Central and South America Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Glucoraphanin and Sulforaphane Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Brassica Corporation Information
Table 51. Brassica Description and Major Businesses
Table 52. Brassica Product Models, Descriptions and Specifications
Table 53. Brassica Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 54. Brassica Sales Value Proportion by Product in 2024
Table 55. Brassica Sales Value Proportion by Application in 2024
Table 56. Brassica Sales Value Proportion by Geographic Area in 2024
Table 57. Brassica Glucoraphanin and Sulforaphane SWOT Analysis
Table 58. Brassica Recent Developments
Table 59. CS Health Corporation Information
Table 60. CS Health Description and Major Businesses
Table 61. CS Health Product Models, Descriptions and Specifications
Table 62. CS Health Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 63. CS Health Sales Value Proportion by Product in 2024
Table 64. CS Health Sales Value Proportion by Application in 2024
Table 65. CS Health Sales Value Proportion by Geographic Area in 2024
Table 66. CS Health Glucoraphanin and Sulforaphane SWOT Analysis
Table 67. CS Health Recent Developments
Table 68. Ingood by Olga Corporation Information
Table 69. Ingood by Olga Description and Major Businesses
Table 70. Ingood by Olga Product Models, Descriptions and Specifications
Table 71. Ingood by Olga Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 72. Ingood by Olga Sales Value Proportion by Product in 2024
Table 73. Ingood by Olga Sales Value Proportion by Application in 2024
Table 74. Ingood by Olga Sales Value Proportion by Geographic Area in 2024
Table 75. Ingood by Olga Glucoraphanin and Sulforaphane SWOT Analysis
Table 76. Ingood by Olga Recent Developments
Table 77. ETChem Corporation Information
Table 78. ETChem Description and Major Businesses
Table 79. ETChem Product Models, Descriptions and Specifications
Table 80. ETChem Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 81. ETChem Sales Value Proportion by Product in 2024
Table 82. ETChem Sales Value Proportion by Application in 2024
Table 83. ETChem Sales Value Proportion by Geographic Area in 2024
Table 84. ETChem Glucoraphanin and Sulforaphane SWOT Analysis
Table 85. ETChem Recent Developments
Table 86. Pioneer Herb Industrial Corporation Information
Table 87. Pioneer Herb Industrial Description and Major Businesses
Table 88. Pioneer Herb Industrial Product Models, Descriptions and Specifications
Table 89. Pioneer Herb Industrial Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Pioneer Herb Industrial Sales Value Proportion by Product in 2024
Table 91. Pioneer Herb Industrial Sales Value Proportion by Application in 2024
Table 92. Pioneer Herb Industrial Sales Value Proportion by Geographic Area in 2024
Table 93. Pioneer Herb Industrial Glucoraphanin and Sulforaphane SWOT Analysis
Table 94. Pioneer Herb Industrial Recent Developments
Table 95. Shanxi Yian Corporation Information
Table 96. Shanxi Yian Description and Major Businesses
Table 97. Shanxi Yian Product Models, Descriptions and Specifications
Table 98. Shanxi Yian Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 99. Shanxi Yian Recent Developments
Table 100. Anhui Bensentang Biotechnology Corporation Information
Table 101. Anhui Bensentang Biotechnology Description and Major Businesses
Table 102. Anhui Bensentang Biotechnology Product Models, Descriptions and Specifications
Table 103. Anhui Bensentang Biotechnology Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 104. Anhui Bensentang Biotechnology Recent Developments
Table 105. Key Raw Materials Distribution
Table 106. Raw Materials Key Suppliers
Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 108. Milestones in Production Technology Evolution
Table 109. Distributors List
Table 110. Market Trends and Market Evolution
Table 111. Market Drivers and Opportunities
Table 112. Market Challenges, Risks, and Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucoraphanin and Sulforaphane Product Picture
Figure 2. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Glucoraphanin Product Picture
Figure 4. Sulforaphane Product Picture
Figure 5. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Health Products
Figure 7. Functional Foods
Figure 8. Pharmaceutical
Figure 9. Others
Figure 10. Glucoraphanin and Sulforaphane Report Years Considered
Figure 11. Global Glucoraphanin and Sulforaphane Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 13. Global Glucoraphanin and Sulforaphane Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Glucoraphanin and Sulforaphane Revenue Market Share by Region (2020-2031)
Figure 15. Global Glucoraphanin and Sulforaphane Sales (2020-2031) & (Kg)
Figure 16. Global Glucoraphanin and Sulforaphane Sales (CAGR) by Region (2020-2031) (Kg)
Figure 17. Global Glucoraphanin and Sulforaphane Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Glucoraphanin and Sulforaphane Sales Volume Market Share in 2024
Figure 19. Global Glucoraphanin and Sulforaphane Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Glucoraphanin Revenue Market Share by Manufacturer in 2024
Figure 22. Sulforaphane Revenue Market Share by Manufacturer in 2024
Figure 23. Global Glucoraphanin and Sulforaphane Sales Market Share by Type (2020-2031)
Figure 24. Global Glucoraphanin and Sulforaphane Revenue Market Share by Type (2020-2031)
Figure 25. Global Glucoraphanin and Sulforaphane Sales Market Share by Application (2020-2031)
Figure 26. Global Glucoraphanin and Sulforaphane Revenue Market Share by Application (2020-2031)
Figure 27. North America Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 28. North America Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 30. North America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020- 2031)
Figure 31. North America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 33. North America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 38. Europe Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 40. Europe Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020-2031)
Figure 41. Europe Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 43. Europe Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 45. France Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 50. Asia-Pacific Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020- 2031)
Figure 53. Asia-Pacific Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 55. Asia-Pacific Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 60. India Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 62. Central and South America Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2021-2031)
Figure 65. Central and South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 67. Central and South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 71. Middle East and Africa Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2021-2031)
Figure 74. South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 76. Middle East and Africa Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 81. Glucoraphanin and Sulforaphane Industry Chain Mapping
Figure 82. Regional Glucoraphanin and Sulforaphane Manufacturing Base Distribution (%)
Figure 83. Global Glucoraphanin and Sulforaphane Production Market Share by Region (2020-2031)
Figure 84. Glucoraphanin and Sulforaphane Production Process
Figure 85. Regional Glucoraphanin and Sulforaphane Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Table 1. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Glucoraphanin and Sulforaphane Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Glucoraphanin and Sulforaphane Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Glucoraphanin and Sulforaphane Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Glucoraphanin and Sulforaphane Sales by Region (2020-2025) & (Kg)
Table 8. Global Glucoraphanin and Sulforaphane Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Glucoraphanin and Sulforaphane Sales by Manufacturers (2020-2025) & (Kg)
Table 11. Global Glucoraphanin and Sulforaphane Sales Share by Manufacturers (2020-2025)
Table 12. Global Glucoraphanin and Sulforaphane Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Glucoraphanin and Sulforaphane Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Glucoraphanin and Sulforaphane by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucoraphanin and Sulforaphane as of 2024)
Table 16. Global Glucoraphanin and Sulforaphane Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Glucoraphanin and Sulforaphane Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
Table 18. Key Manufacturers Glucoraphanin and Sulforaphane Manufacturing Base and Headquarters
Table 19. Global Glucoraphanin and Sulforaphane Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Glucoraphanin and Sulforaphane Sales by Type (2020-2025) & (Kg)
Table 23. Global Glucoraphanin and Sulforaphane Sales by Type (2026-2031) & (Kg)
Table 24. Global Glucoraphanin and Sulforaphane Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Glucoraphanin and Sulforaphane Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Glucoraphanin and Sulforaphane ASP by Type (2020-2031) & (US$/Kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Glucoraphanin and Sulforaphane Sales by Application (2020-2025) & (Kg)
Table 29. Global Glucoraphanin and Sulforaphane Sales by Application (2026-2031) & (Kg)
Table 30. Glucoraphanin and Sulforaphane High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Glucoraphanin and Sulforaphane Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Glucoraphanin and Sulforaphane Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Glucoraphanin and Sulforaphane ASP by Application (2020-2031) & (US$/Kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 37. North America Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 40. Europe Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Glucoraphanin and Sulforaphane Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Glucoraphanin and Sulforaphane Growth Accelerators and Market Barriers
Table 45. Southeast Asia Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Glucoraphanin and Sulforaphane Investment Opportunities and Key Challenges
Table 47. Central and South America Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Glucoraphanin and Sulforaphane Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Glucoraphanin and Sulforaphane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Brassica Corporation Information
Table 51. Brassica Description and Major Businesses
Table 52. Brassica Product Models, Descriptions and Specifications
Table 53. Brassica Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 54. Brassica Sales Value Proportion by Product in 2024
Table 55. Brassica Sales Value Proportion by Application in 2024
Table 56. Brassica Sales Value Proportion by Geographic Area in 2024
Table 57. Brassica Glucoraphanin and Sulforaphane SWOT Analysis
Table 58. Brassica Recent Developments
Table 59. CS Health Corporation Information
Table 60. CS Health Description and Major Businesses
Table 61. CS Health Product Models, Descriptions and Specifications
Table 62. CS Health Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 63. CS Health Sales Value Proportion by Product in 2024
Table 64. CS Health Sales Value Proportion by Application in 2024
Table 65. CS Health Sales Value Proportion by Geographic Area in 2024
Table 66. CS Health Glucoraphanin and Sulforaphane SWOT Analysis
Table 67. CS Health Recent Developments
Table 68. Ingood by Olga Corporation Information
Table 69. Ingood by Olga Description and Major Businesses
Table 70. Ingood by Olga Product Models, Descriptions and Specifications
Table 71. Ingood by Olga Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 72. Ingood by Olga Sales Value Proportion by Product in 2024
Table 73. Ingood by Olga Sales Value Proportion by Application in 2024
Table 74. Ingood by Olga Sales Value Proportion by Geographic Area in 2024
Table 75. Ingood by Olga Glucoraphanin and Sulforaphane SWOT Analysis
Table 76. Ingood by Olga Recent Developments
Table 77. ETChem Corporation Information
Table 78. ETChem Description and Major Businesses
Table 79. ETChem Product Models, Descriptions and Specifications
Table 80. ETChem Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 81. ETChem Sales Value Proportion by Product in 2024
Table 82. ETChem Sales Value Proportion by Application in 2024
Table 83. ETChem Sales Value Proportion by Geographic Area in 2024
Table 84. ETChem Glucoraphanin and Sulforaphane SWOT Analysis
Table 85. ETChem Recent Developments
Table 86. Pioneer Herb Industrial Corporation Information
Table 87. Pioneer Herb Industrial Description and Major Businesses
Table 88. Pioneer Herb Industrial Product Models, Descriptions and Specifications
Table 89. Pioneer Herb Industrial Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Pioneer Herb Industrial Sales Value Proportion by Product in 2024
Table 91. Pioneer Herb Industrial Sales Value Proportion by Application in 2024
Table 92. Pioneer Herb Industrial Sales Value Proportion by Geographic Area in 2024
Table 93. Pioneer Herb Industrial Glucoraphanin and Sulforaphane SWOT Analysis
Table 94. Pioneer Herb Industrial Recent Developments
Table 95. Shanxi Yian Corporation Information
Table 96. Shanxi Yian Description and Major Businesses
Table 97. Shanxi Yian Product Models, Descriptions and Specifications
Table 98. Shanxi Yian Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 99. Shanxi Yian Recent Developments
Table 100. Anhui Bensentang Biotechnology Corporation Information
Table 101. Anhui Bensentang Biotechnology Description and Major Businesses
Table 102. Anhui Bensentang Biotechnology Product Models, Descriptions and Specifications
Table 103. Anhui Bensentang Biotechnology Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 104. Anhui Bensentang Biotechnology Recent Developments
Table 105. Key Raw Materials Distribution
Table 106. Raw Materials Key Suppliers
Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 108. Milestones in Production Technology Evolution
Table 109. Distributors List
Table 110. Market Trends and Market Evolution
Table 111. Market Drivers and Opportunities
Table 112. Market Challenges, Risks, and Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucoraphanin and Sulforaphane Product Picture
Figure 2. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Glucoraphanin Product Picture
Figure 4. Sulforaphane Product Picture
Figure 5. Global Glucoraphanin and Sulforaphane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Health Products
Figure 7. Functional Foods
Figure 8. Pharmaceutical
Figure 9. Others
Figure 10. Glucoraphanin and Sulforaphane Report Years Considered
Figure 11. Global Glucoraphanin and Sulforaphane Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 13. Global Glucoraphanin and Sulforaphane Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Glucoraphanin and Sulforaphane Revenue Market Share by Region (2020-2031)
Figure 15. Global Glucoraphanin and Sulforaphane Sales (2020-2031) & (Kg)
Figure 16. Global Glucoraphanin and Sulforaphane Sales (CAGR) by Region (2020-2031) (Kg)
Figure 17. Global Glucoraphanin and Sulforaphane Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Glucoraphanin and Sulforaphane Sales Volume Market Share in 2024
Figure 19. Global Glucoraphanin and Sulforaphane Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Glucoraphanin Revenue Market Share by Manufacturer in 2024
Figure 22. Sulforaphane Revenue Market Share by Manufacturer in 2024
Figure 23. Global Glucoraphanin and Sulforaphane Sales Market Share by Type (2020-2031)
Figure 24. Global Glucoraphanin and Sulforaphane Revenue Market Share by Type (2020-2031)
Figure 25. Global Glucoraphanin and Sulforaphane Sales Market Share by Application (2020-2031)
Figure 26. Global Glucoraphanin and Sulforaphane Revenue Market Share by Application (2020-2031)
Figure 27. North America Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 28. North America Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 30. North America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020- 2031)
Figure 31. North America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 33. North America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 38. Europe Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 40. Europe Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020-2031)
Figure 41. Europe Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 43. Europe Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 45. France Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 50. Asia-Pacific Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2020- 2031)
Figure 53. Asia-Pacific Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 55. Asia-Pacific Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 60. India Glucoraphanin and Sulforaphane Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 62. Central and South America Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2021-2031)
Figure 65. Central and South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 67. Central and South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Glucoraphanin and Sulforaphane Sales YoY (2020-2031) & (Kg)
Figure 71. Middle East and Africa Glucoraphanin and Sulforaphane Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Glucoraphanin and Sulforaphane Sales Volume (Kg) by Type (2021-2031)
Figure 74. South America Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Glucoraphanin and Sulforaphane Sales Volume (Kg) by Application (2020-2031)
Figure 76. Middle East and Africa Glucoraphanin and Sulforaphane Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Glucoraphanin and Sulforaphane Revenue (2020-2025) & (US$ Million)
Figure 81. Glucoraphanin and Sulforaphane Industry Chain Mapping
Figure 82. Regional Glucoraphanin and Sulforaphane Manufacturing Base Distribution (%)
Figure 83. Global Glucoraphanin and Sulforaphane Production Market Share by Region (2020-2031)
Figure 84. Glucoraphanin and Sulforaphane Production Process
Figure 85. Regional Glucoraphanin and Sulforaphane Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232